Matches in Nanopublications for { ?s ?p "[Ex vivo pretreatment of BMC from patients with ICMP with AVE significantly increased eNOS mRNA expression by 2.1-fold (P < 0.05) and eNOS activity as assessed by ESR by >3-fold (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Ex vivo pretreatment of BMC from patients with ICMP with AVE significantly increased eNOS mRNA expression by 2.1-fold (P < 0.05) and eNOS activity as assessed by ESR by >3-fold (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_assertion description "[Ex vivo pretreatment of BMC from patients with ICMP with AVE significantly increased eNOS mRNA expression by 2.1-fold (P < 0.05) and eNOS activity as assessed by ESR by >3-fold (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_provenance.
- NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_assertion description "[Ex vivo pretreatment of BMC from patients with ICMP with AVE significantly increased eNOS mRNA expression by 2.1-fold (P < 0.05) and eNOS activity as assessed by ESR by >3-fold (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_provenance.